HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  R. McGinnis,et al.  Linkage disequilibrium in the insulin gene region: size variation at the 5' flanking polymorphism and bimodality among "class I" alleles. , 1994, American journal of human genetics.

[3]  A. Arnaiz-Villena,et al.  Susceptibility to insulin-dependent diabetes mellitus and short cytoplasmic ATP-binding domain TAP2*01 alleles. , 1994, Tissue antigens.

[4]  P. Morris.  An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules , 1994 .

[5]  B. Arp,et al.  HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells , 1994, Nature.

[6]  Ronald N. Germain,et al.  MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.

[7]  J. D. Capra,et al.  TAP1 alleles in insulin-dependent diabetes mellitus: a newly defined centromeric boundary of disease susceptibility. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Neefjes,et al.  Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. , 1993, Science.

[9]  C. Boitard,et al.  Protection from insulin‐dependent diabetes mellitus is linked to a peptide transporter gene , 1993, European journal of immunology.

[10]  E. Thorsby,et al.  Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin‐dependent diabetes mellitus , 1993, European journal of immunology.

[11]  J. Slot,et al.  Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi , 1992, Nature.

[12]  T Spies,et al.  Allelic variants of the human putative peptide transporter involved in antigen processing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Green,et al.  Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE study , 1992, The Lancet.

[14]  F. Christiansen,et al.  An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes , 1992, Immunogenetics.

[15]  P. Cresswell,et al.  Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer , 1992, Nature.

[16]  J. Monaco,et al.  MHC class II region encoding proteins related to the muKidrug resistance family of transmembrane transporters , 1990, Nature.

[17]  S. Beck,et al.  Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.

[18]  R. Demars,et al.  A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.

[19]  R E LaPorte,et al.  Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. D. Capra,et al.  Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. , 1990, The New England journal of medicine.

[21]  F. Galibert,et al.  A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. , 1990, The Journal of clinical investigation.

[22]  H. Ljunggren,et al.  Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.

[23]  J. Todd,et al.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Dausset,et al.  HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Todd,et al.  A molecular basis for MHC class II--associated autoimmunity. , 1988, Science.

[26]  J. Todd,et al.  HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.

[27]  M. Spence,et al.  Analysis of human genetic linkage , 1986 .

[28]  P. Terasaki,et al.  HLA and Disease Associations , 1985, Springer New York.

[29]  N. Arnheim,et al.  Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Charles Auffray,et al.  The class II molecules of the human and murine major histocompatibility complex , 1984, Cell.

[31]  N. Petrovsky,et al.  HLA-matched control subjects are essential in studies of susceptibility to IDDM , 2006, Diabetologia.

[32]  J. Bodmer,et al.  Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2 , 2004, Immunogenetics.

[33]  J. Trowsdale,et al.  Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: no association in a population with a high disease incidence. , 1994, Tissue antigens.

[34]  H. Erlich,et al.  MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.

[35]  J. Ott.  Statistical properties of the haplotype relative risk , 1989, Genetic epidemiology.

[36]  G. Thomson.  HLA disease associations: models for insulin dependent diabetes mellitus and the study of complex human genetic disorders. , 1988, Annual review of genetics.

[37]  J. Todd,et al.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. , 1987, Nature.